FGFR1 and T-cell and NK-cell neoplasm: The t(8;22) variant translocation, results in a fusion between BCR (breakpoint cluster region) and FGFR1 which is clinically distinct from the myeloid/T-cell neoplasms of other variant FGFR1 fusions [5], [6], [7], [8], [9], [10], [11].